Capability of supplying injectable APIs globally from key starting material to intermediates to finished API products
Malur API Unit - Established in the year 2006
Multi product generic APIs.
Anti-cancer Products.
Specialized in manufacturing of high value, low volume non-sterile APIs for injectable formulations and supplying to US, EU, Canada & ROW markets.
Overview
This site is comprised of 6 acres of land with three manufacturing blocks.
Historically this site produced Anti-cancer Products & Multi product generic APIs, approved by USFDA , TGA , COPP (WHO-GMP), EU written confirmation , ISO 9001:2015 & GMP certified.
This facility has 60 reactors with over 33 KL of handling capacity together with several agitated nutsche filters, vacuum tray dryers and production equipment.
Equipped with material handling systems, utility systems, dedicated Quality Assurance, dedicated testing lab, dedicated microbiology lab, process troubleshooting lab & Information technology support the API manufacturing plant.
